Jorge Lascano

Inhaled mRNA therapy for treatment of cystic fibrosis: Interim results of a randomized, double‐blind, placebo‐controlled phase 1/2 clinical study

Steven M. Rowe, Jonathan B. Zuckerman, Daniel Dorgan et al. · Journal of Cystic Fibrosis · 2023 · 135 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +10

Anticoagulation and Antiplatelet Therapy for Prevention of Venous and Arterial Thrombotic Events in Critically Ill Patients With COVID-19: COVID-PACT

Erin A. Bohula, David D. Berg, Mathew S. Lopes et al. · Circulation · 2022 · 82 citations · Full text

Medicine, Hematology, Pharmacotherapy +17

Gender and racial disparities in lung transplantation in the United States

Leonard Riley, Jorge Lascano · The Journal of Heart and Lung Transplantation · 2021 · 52 citations

Medicine, Gender Studies, Surgery +14

Long-term safety and efficacy of tezacaftor–ivacaftor in individuals with cystic fibrosis aged 12 years or older who are homozygous or heterozygous for Phe508del CFTR (EXTEND): an open-label extension study

Patrick A. Flume, Reta Fischer Biner, D.G. Downey et al. · The Lancet Respiratory Medicine · 2021 · 51 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +13

Risk factors for hepatic steatosis in adults with cystic fibrosis: Similarities to non-alcoholic fatty liver disease

Fares Ayoub, Cesar Trillo‐Alvarez, Giuseppe Morelli et al. · World Journal of Hepatology · 2018 · 45 citations · Full text

Medicine, Internal Medicine, Radiology +17